YH1 in Poorly Controlled Type 2 Diabetes
The Efficacy and Safety of Concentrated Herbal Extract Granules, YH1, as an Add-On Medication in Poorly Controlled Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Sponsor: Chang Gung Memorial Hospital
Listed as NCT02752880, this PHASE2/PHASE3 trial focuses on Type 2 Diabetes and remains completed. Sponsored by Chang Gung Memorial Hospital, it has been updated 11 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2_PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2_PHASE3
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Aug 2019 [monthly]
Completed PHASE2_PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2018 — Mar 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2018 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
For direct contact, visit the study record on ClinicalTrials.gov .